Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas

Aims: To identify immunostaining patterns that are predictive for p53 mutations and to investigate whether p53 mutations are associated with established risk factors for oral squamous cell carcinoma (OSCC). Methods: Fifty five OSCCs were investigated for p53 protein expression by immunohistochemistry (IHC). Ten of these cases, including five p53 immunopositive and five p53 immunonegative cases, were subjected to microdissection of representative tumour areas followed by sequence analysis for the detection of TP53 mutations. Results: Paired IHC and sequence analysis revealed that p53 immunoexpression in more than 25% of tumour cells was indicative of TP53 mutations, whereas p53 immunonegativity was not informative. Therefore, for p53 immunohistochemical interpretation, p53 immunonegative cases were excluded from the analysis and the cut off value for p53 immunoexpression was set at 25%. Of the OSCCs showing any p53 immunoexpression, 64% revealed staining in more than 25% of the tumour cells. p53 immunoexpression in more than 25% of the neoplastic cells was significantly associated with smoking but not with alcohol consumption. No significant association with smoking habits was found when OSCCs were dichotomised into p53 immunonegative and p53 immunopositive. Conclusions: In OSCCs the following conclusions can be made: (1) p53 immunonegativity is not informative for TP53 mutations; (2) 25% p53 immunopositive cells appears to be a good cut off value to predict TP53 mutations; (3) p53 immunostaining patterns that appeared to be predictive for TP53 mutations were associated with the smoking habits of the patients.

[1]  P. Maxwell,et al.  Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. , 2002, Journal of clinical pathology.

[2]  N. Ahuja,et al.  Aging, methylation and cancer. , 2000, Histology and histopathology.

[3]  G. Snow,et al.  p53 immunoexpression in non‐malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management , 2000, The Journal of pathology.

[4]  M. Gulley,et al.  A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  N D Le,et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  G. Clayman,et al.  Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  J. Jen,et al.  Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Califano,et al.  Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. , 1999, Journal of the National Cancer Institute.

[9]  A. Kropveld,et al.  Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[10]  T. Hideshima,et al.  p53 mutations predict non-small cell lung carcinoma response to radiotherapy. , 1999, Cancer letters.

[11]  S. Finkelstein,et al.  p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma , 1998, Cancer.

[12]  G. Snow,et al.  p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma , 1998, The Journal of pathology.

[13]  T. Helliwell,et al.  p53 Expression and p53 Gene Mutation in Oral Cancer and Dysplasia , 1998, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[14]  C. Larsen.  METHYLATION ET CANCER , 1997 .

[15]  C. la Vecchia,et al.  Epidemiology and prevention of oral cancer. , 1997, Oral oncology.

[16]  S. Leurgans,et al.  Mutation of p53 in Squamous Cell Cancer of the Head and Neck: Relationship to Tumor Cell Proliferation , 1997, The Laryngoscope.

[17]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[18]  G. Viale,et al.  p53 protein accumulation and p53 gene mutation in esophageal carcinoma , 1997, Cancer.

[19]  M. Tang,et al.  Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.

[20]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[21]  M. Eriksson,et al.  A non-random deletion in the p53 gene in oral squamous cell carcinoma. , 1996, British Journal of Cancer.

[22]  A. Fair,et al.  Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. , 1996, Carcinogenesis.

[23]  G. Ogden,et al.  The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  C. Tzeng,et al.  Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[25]  G. Snow,et al.  Value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas. , 1995, European journal of cancer. Part B, Oral oncology.

[26]  S. Syrjänen,et al.  Implications of the p53 tumor-suppressor gene in clinical oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  R H Hruban,et al.  Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[28]  E. Brambilla,et al.  Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. , 1995, Acta oto-laryngologica.

[29]  E. Wynder,et al.  The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. , 1994, International journal of epidemiology.

[30]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[31]  Yao-Tseng Chen,et al.  Overexpression of p53 Protein in Squamous Cell Carcinomas of Head and Neck Without Apparent Gene Mutations , 1994, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[32]  W. Hong,et al.  Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. , 1994, Cancer research.

[33]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[34]  D. Carbone,et al.  Polymorphism at codon 213 within the p53 gene. , 1991, Oncogene.

[35]  G. Snow,et al.  Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. , 1996, European journal of cancer. Part B, Oral oncology.

[36]  D. Spandidos,et al.  p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol. , 1994, Cancer detection and prevention.

[37]  W. Yeudall,et al.  Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. , 1993, European journal of cancer. Part B, Oral oncology.

[38]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.